back to overview

news

MTIP leads the €20 million growth financing round in LynxCare

June 21, 2022 + Jessica Di Palo
3 Min read

Largest capital round ever in digital health in Belgium

We are delighted to announce MTIP Fund II’s sixth investment in LynxCare, the Belgian Health Data Scale-Up company. MTIP led the €20 million growth financing round. The capital will be used to strengthen its international position in the world of healthtech data and to drive the team’s growth. Other investors include Elaia (FR) and the company’s early-stage investors Heran Partners (BE), BTOV (DE), and PMV (BE). At the same time, Lynxcare announces a strategic partnership with PSIH Group, the market-leader in clinical business intelligence in France. Through this partnership, 66% of French hospital groups could gain access to LynxCare’s software.

Hospitals have been digitised for more than 15 years and today they have an enormous amount of data at their disposal. However, an estimated 90% of that data is not used, while it is very important for good patient care and scientific research. After all, this data shows the actual outcome of treatments, a reality that may differ from what clinical studies indicate. LynxCare enables hospitals to unlock their vast amounts of siloed, legacy data using AI (Artificial Intelligence) and NLP (Natural Language Processing), to gain insights into the Real-World performance of treatments and fuel clinical insights for doctors and researchers to improve patient outcomes. Launched in 2015 by Georges De Feu (Pharm D. and Dries Hens (M.D.), LynxCare’s clinical data platform is accelerating research at the leading Health Systems across Europe and North America.

Unlocking previously unavailable insights for scientific research 

The investment round follows major breakthroughs for LynxCare. In 2021, the company announced its collaboration EHDEN, the program supported by the European Commission to promote access to health data for scientific research. Together with EHDEN, LynxCare supports the ethical use of data based on an open source data model, allowing research within a strict ethical framework and without privacy violation. In this context, LynxCare announced several research collaborations with Life Sciences companies i.e. AstraZeneca, Johnson & Johnson, Pfizer.

By raising €20 million– the largest capital round ever in digital health in Belgium – the company can accelerate the international rollout of its platform. For LynxCare, the support of these investors is a testament of the significance of data in healthcare. “I’m proud that as a Belgian-European company, we’re taking the lead in unlocking healthcare data globally. I’m thankful to our dedicated team, and our CFO Kenny Willems in particular, for making this funding round possible”, says  Georges De Feu, Co-Founder and CEO of LynxCare. “We’re at the forefront of a data revolution in healthcare where the patient’s data is at the center, we want to take the lead here”.

Untapped value 

Lead investor MTIP recognizes the untapped value of real-world data at the intersection of life sciences and healthcare. Dr. Christoph Kausch, Managing Partner at MTIP states: “the timing is perfect to partner with the European health data leader and drive forward the real-world data agenda to enable better healthcare outcomes.” Wanja Humanes, who joins the Board of Directors on behalf of MTIP continues: “We were very impressed by the level of interest that LynxCare is seeing from both well-established players in the healthcare and life sciences industries as they enable them to take advantage of healthcare data at scale. We are incredibly proud to be partnering with this outstanding company and its founders.”

French investment partner Elaia believes that unlocking the potential of longitudinal healthcare data will be critical to solve better global health issues. “LynxCare perfectly fits our vision and is bringing the best solution for hospital data on the market”, states Elaia-partner Samantha Jerusalmy. “The two complementary co-founders Georges De Feu and Dries Hens have made a tremendous work building a solid top-management team around them, relying on their successful entrepreneurial background. We are looking forward to backing them in this new development phase.”

Strategic partnership to boost internationalization 

Coincidentally with this financing round, LynxCare is forming a strategic partnership with PSIH. The French market-leader in clinical business intelligence will enable the roll-out of the LynxCare platform within their client base of over a thousand hospitals. “Our partnership with LynxCare will accelerate setup of hospital clinical data warehouses providing unmatched data for medical research, quality of care, patients pathway monitoring, and analytics to improve treatments”, says Jean-Baptiste Angeloglou, General Director of PSIH group. “PSIH group will bring its deep expertise on structured data treatment and business intelligence, combined with LynxCare’s state of the art capabilities to structure electronic medical records with innovative NLP algorithms.”

About LynxCare 

LynxCare is the Big Data market leader in healthcare. With an AI-driven data platform, they help hospitals unlock previously unavailable clinical data for better patient care and scientific research. Founded in 2015 by Georges De Feu (pharmacist) and Dries Hens (physician), LynxCare is today a rapidly growing Belgian scale-up. They currently employ 35 people, including doctors, biomedical scientists, data specialists and more than 10 researchers (PhD).  They work with leading hospitals in Europe and the United States, and facilitate scientific research for Life Sciences companies such as AstraZeneca, Pfizer, Novartis within a strict ethical and legal framework.

More information via https://www.lynx.care/

About MTIP 

MTIP is a leading Swiss-based growth equity firm investing in European health tech companies. We leverage our deep sector expertise to help the founders scale up successful and sustainable digital health businesses. At MTIP, we are driven by the mission to empower health tech innovation with a potential to impact and improve millions of lives. Visit www.mtip.ch to learn more.

Share the Article

news

MTIP leads the €20 million growth financing round in LynxCare

Largest capital round ever in digital health in Belgium

blog

Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development

blog

The psychology of decision making

What makes a good investor?

blog

Revolutionizing medical triage with artificial intelligence

Mediktor's solution for medical triage

news

MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

MTIP Fund II is closed!

blog

Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!

news

MTIP invests in Mediktor

New investment in Mediktor

blog

SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right

news

MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round

news

MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia

blog

Private Equity 101: Part one – Glossary

Are you new to the healthtech space?

blog

Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey

blog

Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

blog news

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations

news

MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II

blog

How to pitch to a healthtech Investor

Blog Pitching

news

MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health

news

MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020

press

4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour

news

MTIP invests in Trialbee

New investment in Trialbee

news

TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round

news

The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April

news

MTIP has sucessfully exited Blueprint Genetics

Blueprint exit January 2020

news

New MTIP investment in Oviva

New investment in Oviva